- Amicus will make an upfront cash payment of $100 million
- The company also announced closing a $150 million term loan to help finance the acquisition and development costs
- ... read more
Pfizer Inc. (NYSE:PFE) announced on 9/... read more
MaaT Pharma announced on 9/18/19 the presentation of the analysis of MaaT Pharma’s lead biotherapeutic, MaaT013, demonstrating its drug product characteristics using MaaT Pharma’s proprietary big... read more
argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company... read more
Exelixis, Inc. (NASDAQ:EXEL) announced on 9/19/18 that its... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,